TY - JOUR
T1 - Estimates of insulin sensitivity and β-cell function in children and adolescents with and without components of the metabolic syndrome
AU - Frithioff-Bøjsøe, Christine
AU - Trier, Cæcilie
AU - Esmann Fonvig, Cilius
AU - Nissen, Anne
AU - Kloppenborg, Julie Tonsgaard
AU - Mollerup, Pernille Maria
AU - Bjerrum, Poul Jannik
AU - Pedersen, Oluf
AU - Hansen, Torben
AU - Holm, Jens-Christian
N1 - © Polish Society for Pediatric Endocrinology and Diabetology.
PY - 2017
Y1 - 2017
N2 - Introduction: The accumulation of components of the metabolic syndrome (MetS) is associated with a disturbed glucose metabolism in obese children. Aim of study: The aim of the present study was to evaluate the association between MetS and estimates of insulin sensitivity and β-cell function obtained from oral glucose tolerance test (OGTT)-derived indices in lean and obese children. Material and methods: A 2-hour OGTT was administered in 83 children aged 7-17 years. 47 children were obese and recruited from a childhood obesity clinic and 36 were lean age- and sex-matched controls. Surrogate measures of insulin sensitivity and β-cell function were assessed by the OGTT-derived indices: the Matsuda index, the insulinogenic index, and the oral disposition index. The severity of MetS was assessed by measures of waist circumference, blood pressure, and fasting levels of triglycerides, high-density lipoprotein cholesterol, and glucose. Results: The 83 children were allocated to one of three groups according to the number of components of MetS: the median body mass index standard deviation score was 0.2 (range -0.6-2.9) in the low MetS risk group (n=36), 2.8 (0.1-4.1) in the high MetS risk group (n=25), and 2.9 (2.1-4.4) in the MetS group (n=22). An increasing number of MetS components were associated with a lower insulin sensitivity and an altered β-cell function according to the Matsuda index (p<0.0001), the insulinogenic index (p<0.0001), and the oral disposition index (p=0.005). Conclusions: Children burdened by the accumulation of components of MetS exhibited a disturbed glucose metabolism as expressed by lowered peripheral insulin sensitivity and β-cell function.
AB - Introduction: The accumulation of components of the metabolic syndrome (MetS) is associated with a disturbed glucose metabolism in obese children. Aim of study: The aim of the present study was to evaluate the association between MetS and estimates of insulin sensitivity and β-cell function obtained from oral glucose tolerance test (OGTT)-derived indices in lean and obese children. Material and methods: A 2-hour OGTT was administered in 83 children aged 7-17 years. 47 children were obese and recruited from a childhood obesity clinic and 36 were lean age- and sex-matched controls. Surrogate measures of insulin sensitivity and β-cell function were assessed by the OGTT-derived indices: the Matsuda index, the insulinogenic index, and the oral disposition index. The severity of MetS was assessed by measures of waist circumference, blood pressure, and fasting levels of triglycerides, high-density lipoprotein cholesterol, and glucose. Results: The 83 children were allocated to one of three groups according to the number of components of MetS: the median body mass index standard deviation score was 0.2 (range -0.6-2.9) in the low MetS risk group (n=36), 2.8 (0.1-4.1) in the high MetS risk group (n=25), and 2.9 (2.1-4.4) in the MetS group (n=22). An increasing number of MetS components were associated with a lower insulin sensitivity and an altered β-cell function according to the Matsuda index (p<0.0001), the insulinogenic index (p<0.0001), and the oral disposition index (p=0.005). Conclusions: Children burdened by the accumulation of components of MetS exhibited a disturbed glucose metabolism as expressed by lowered peripheral insulin sensitivity and β-cell function.
U2 - 10.18544/pedm-23.03.0083
DO - 10.18544/pedm-23.03.0083
M3 - Journal article
C2 - 29253032
SN - 2081-237X
VL - 23
SP - 122
EP - 129
JO - Pediatric Endocrinology, Diabetes and Metabolism
JF - Pediatric Endocrinology, Diabetes and Metabolism
IS - 3
ER -